Table 1:
Demographic and clinical characteristics (N = 29)
| Patient Characteristics | Results |
|---|---|
| Sex, n (%) | |
| Males | 17 (58.6) |
| Females | 12 (41.6) |
| Age, n (%) | |
| <18 y | 15 (51.7) |
| ≥18 y | 14 (48.3) |
| Age at first eventa, median (IQR), y | −12 (6–36) |
| Initial clinical presentation, n (%) | |
| Ischemic stroke | 10 (34.5) |
| Intracerebral bleed | 5 (17.2) |
| TIA | 7 (24.2) |
| Syncope | 1 (3.4) |
| Seizure | 6 (20.7) |
| Recurrent events, n (%) | 22 (75.9) |
| Ischemic stroke | 10 (34.5) |
| Intracranial bleed (intraventricular hemorrhage) | 2 (6.9) |
| Positive family history of MMD, n (%) | 2 (6.9) |
| NIHSS on admission, median (IQR) | 1 (0–3) |
| mRS on admission, median (IQR) | 1 (0–3) |
Note:–IQR indicates interquartile range; mRS, modified Rankin scale.
a
The mean ± SD interval between the first symptom and HRVWI was 64.7 ± 80.7 months.